Cytomegalovirus glycoprotein b sequence variation among japanese bone marrow transplant recipients

Intervirology

Volumn 40, Issue 4, 1997, Pages 215-219

  Wada, Kaoru ^a   Mizuno, Shinichi ^b   Kato, Koji ^c   Kamiya, Tadashi ^a   Ozawa, Kazuo ^a  

^a JAPANESE RED CROSS SOCIETY   (Japan)

^b Daido Hospital   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

Bone marrow transplantation; Cytomegalovirus; Glycoprotein B variation; Human

Indexed keywords

VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CAUCASIAN; CELL CULTURE; CLINICAL ARTICLE; GENE AMPLIFICATION; HUMAN; HUMAN CYTOMEGALOVIRUS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 2642683232     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150549     Document Type: Article

References (20)

1. Forman SJ, Zaia JA: Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: Where do we stand? Blood 1994;83:2392-2398.
2. Chec MS, Bankier AT, Beck S, Bohni R, Brown CM, Cerny R, Horsnell T, Hutchison CA III, Kouzarides T, Martingetti JA, Preddie E, Satchwell SC, Tomlinson P, Weston KM, Barrell BG: Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD 169. Curr Top Microbiol Immunol 1990;154:125-169.
3. Utz U, Britt W, Vugler L, Mach M: Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus, J Virol 1989: 63:1995-2001.
4. Marshall GS, Rabalais GP, Stout GG, Waldeyer SL: Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity, J Infect Dis 1992:165:381-384.
5. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L: Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells, Virology 1993:197: 143-158.
6. Tugizov S, Navarro D, Paz P, Wang Y, Qadri L, Pereira L: Function of human cytomegalovirus glycoprotein B: Syncytium formation in cells constitutivcly expressing gB is blocked by virus-neutralizing antibodies, Virology 1994; 201:263-276.
7. Spaetc RR, Thayer RM, Probert WS, Masiarz FR, Chamberlain S, Rasmussen L, Merigan TC, Pachl C: Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage, Virology 1988;167:207-225.
8. Chou S, Dennison KM: Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes, J Infect Dis 1991;163:1229-1234.
9. Chou S: Comparative analysis of sequence variation in gpl 16 and gp55 components of glycoprotein B of human cytomegalovirus, Virology 1992:188:388-390.
10. Fries BC, Chou S, Bocckh M, Torok-Storb B: Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients, J Infect Dis 1994:169: 769-774.
11. Crangc MP, Kouzaridcs T, Bankier AT, Satch-well S, Weston K, Tomlinson P, Barrell B, Hart H, Bell SE, Minzon AC, Smith GL: Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus, EMBOJ 1986;5:3057-3063.
12. Clark JM: Novel non-templatcd nucleotide addition reactions catalyzed by procaryotic and eurocaryotic DNA polymerases, Nucleic Acids Res 1988;16: 9677-9686.
13. Sanger F, Nicklen S, Coulsen AR: DNA sequencing with chain-termination inhibitors, Proc Natl Acad Sci USA 1977:74:5463-5467.
14. Shiu SYW, Chan KM, LoSKF, Ip KWV, Yuen KY, Heath RB: Sequence variation of the amino-terminal antigenic domains of glycoprotein B of human cytomegalovirus strains isolated from Chinese patients, Arch Virol 1994:137: 133-138.
15. Chou S: Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus, J Infect Dis 1992;166:604-607.
16. Lehner R, StammingcrT, Mach M: Comparative sequence analysis of human cytomegalovirus strains, J Clin Microbiol 1991;29:2494-2502.
17. Tugizov S, Wang Y, Quadri I, Navarro D, Maidji E, Pereira L: Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation, Virology 1995;209:580-591.
18. Roy DM, Grundy JE, Emery VC: Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: Comparison of isolates from renal transplant recipients and AIDS patients, J Gen Virol 1993:74:2499-2505.
19. Chou S: Acquisition of donor strains of cytomegalovirus by renal-transplant recipients, N Engl J Med 1986;314:1418-1423.
20. Chou S: Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients, J Infect Dis 1989:160:16.